Detalhe da pesquisa
1.
Evaluation of Commercial Myxomatosis Vaccines against Recombinant Myxoma Virus (ha-MYXV) in Iberian Hare and Wild Rabbit.
Vaccines (Basel)
; 10(3)2022 Feb 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35334987